HEERLEN, Netherlands, Aug. 27, 2019 /PRNewswire/ -- Royal DSM, a global science-based company in Nutrition, Health and Sustainable Living, has completed the creation of a 75/25 joint venture (JV) with Nenter & Co., Inc., as first announced on 29 January 2019 [https://www.dsm.com/corporate/news/news-archive/2019/01-19-dsm-announces-jv-with-nenter-to-produce-vitamin-e.html]. The JV acquired all Nenter's Jingzhou Vitamin E production and related assets. The JV will immediately start implementing the anticipated upgrade activities to ensure compliance with DSM's safety, health and environmental standards, and therefore will stop production. The shutdown will last as long as needed to finalize these significant upgrades.
https://mma.prnewswire.com/media/657851/DSM_Logo.jpg [https://mma.prnewswire.com/media/657851/DSM_Logo.jpg ]
The JV now owns and will operate the vitamin E production facilities in Jingzhou, Hubei, China and has a minority shareholding in Nenter's Shishou facility, in Hubei, China, where an intermediate for vitamin E is produced. The JV will produce vitamin E exclusively for DSM.
The JV will upgrade and refurbish the facilities to secure a high-quality and sustainable supply of vitamin E, which complies with DSM's safety, health and environmental standards.
The shutdown that was already planned as from the beginning of September will be extended to enable the implementation of these upgrade activities. As soon as there is more clarity on the total duration of the shutdown, an update will be given.
DSM - Bright Science. Brighter Living.(TM)
Royal DSM is a global, purpose-led, science-based company active in Nutrition, Health and Sustainable Living. DSM's purpose is to create brighter lives for all. DSM addresses with its products and solutions some of the world's biggest challenges while simultaneously creating economic, environmental and societal value for all its stakeholders - customers, employees, shareholders, and society at large. DSM delivers innovative solutions for human nutrition, animal nutrition, personal care and aroma, medical devices, green products and applications, and new mobility and connectivity. DSM and its associated companies deliver annual net sales of about EUR10 billion with approximately 23,000 employees. The company was founded in 1902 and is listed on Euronext Amsterdam. More information can be found at www.dsm.com [http://www.dsm.com/].
Forward-looking statements This press release may contain forward-looking statements with respect to DSM's future (financial) performance and position. Such statements are based on current expectations, estimates and projections of DSM and information currently available to the company. DSM cautions readers that such statements involve certain risks and uncertainties that are difficult to predict and therefore it should be understood that many factors can cause actual performance and position to differ materially from these statements. DSM has no obligation to update the statements contained in this press release, unless required by law. The English language version of the press release is leading.
Logo - https://mma.prnewswire.com/media/657851/DSM_Logo.jpg [https://mma.prnewswire.com/media/657851/DSM_Logo.jpg]
CONTACT: DSM Media Relations: Lieke de Jong, tel. +31 (0) 45 5782420, e-mail email@example.com; DSM Investor Relations:Dave Huizing, tel. +31 (0) 45 5782864, e-mail firstname.lastname@example.org
Web site: http://www.dsm.com/